Molecular Biomedicine/LinkedIn
Nov 23, 2025, 01:42
Exploring the Anti-Inflammatory Power of ML345 – Molecular Biomedicine
Molecular Biomedicine shared a post on LinkedIn:
“ML345 is a potent and selective NLRP3 inflammasome inhibitor with anti-inflammatory activity.”
Title: ML345 is a potent and selective NLRP3 inflammasome inhibitor with anti-inflammatory activity
Authors: Hualong Lin, Xinxin Liang, Weijie Hao, Xiaoli Lu, Bo Li, Xiaohong Wang
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 8, 2025, 06:17New E-Learning Module on Maternal Vaccinations Launched – RCOG
-
Dec 7, 2025, 18:25Thyroid Autoimmunity’s Impact on ART Outcomes Explored – CEOG
-
Dec 7, 2025, 18:23Join Us at the European Parliament on Fertility Crisis – Fertility Europe
-
Dec 7, 2025, 18:20ANDDE Joined The CNPGOGMA – New Era in Gynecology Collaboration – ANDDE
-
Dec 7, 2025, 18:17Gregory Piazza: New Perspectives on Antithrombotic Use During Pregnancy
-
Dec 7, 2025, 18:14New Insights Into Reproductive Health Using AI Technology – CEOG
-
Dec 7, 2025, 18:06Discover Latest Advances at the 2026 Gynecology and Obstetrics Fair – Gynécologie Obstétrique Pratique
-
Dec 7, 2025, 03:12Enhancing Progesterone Signaling in Endometrial Cells – Fertility and Sterility
-
Dec 7, 2025, 03:02Navigating Controversies in Polygenic Embryo Screening – ESHRE